GLP-26 is a HBV capsid assembly modulators (CAM), inhibits HBV DNA replication in Hep AD38 system ( IC 50 =3 nM), and reduces cccDNA by >90% at 1 μM.GLP-26 disrupts the encapsidation of pre-genomic RNA, causes nucleocapsid disassembly and reduces cccDNA pools.In VitroGLP-26 (0.7-1.7 μM; 3 days) reduces secreted HBeAg in HepNTCP-DL cells transfected with HBV/nwild type, with EC 50 values of 0.7 μM. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Cell Viability AssayCell Line: HepNTCP-DL cells Concentration: 0.7-1.7 μM Incubation Time: 3 days Result: Reduced secreted HBeAg in HepNTCP-DL cells.Form:Solid.
Specifications and Purity: ≥98%
Molecular Formula: C19H17F2N3O3
Molecular Weight: 373.35
PubChem CID: 130408536
Isomeric SMILES: CC1=C(N(C(=C1C(=O)C(=O)NCC#C)C)C)C(=O)NC2=CC(=C(C=C2)F)F
- UPC:
- 41115710
- Condition:
- New
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- G651961-5mg
- CAS:
- 2133017-36-2
- Product Size:
- 5mg
akash.verma@cenmed.com
(732) 447-1115





